These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 19601534

  • 21. [Mesalamine-induced hypersensitivity pneumonitis].
    Zamir D, Weizman J, Zamir C, Fireman Z, Weiner P.
    Harefuah; 1999 Jul; 137(1-2):28-30, 87, 86. PubMed ID: 10959271
    [Abstract] [Full Text] [Related]

  • 22. Mesalazine-related lung disease in a patient with ulcerative colitis: A case report.
    Huang PH, Kuo CJ, Lin CW, Cheng YM, Hu HC, Lin CY, Su MY, Chiu CT.
    Medicine (Baltimore); 2018 Nov; 97(48):e13242. PubMed ID: 30508908
    [Abstract] [Full Text] [Related]

  • 23. [Early renal failure caused by mesalazine].
    Musil D.
    Vnitr Lek; 2000 Oct; 46(10):728-31. PubMed ID: 11344635
    [Abstract] [Full Text] [Related]

  • 24. Pure white cell aplasia induced by mesalazine in a patient with ulcerative colitis.
    Frattini F, Crestani S, Vescovi PP, Franchini M.
    Hematology; 2013 May; 18(3):181-2. PubMed ID: 23321335
    [Abstract] [Full Text] [Related]

  • 25. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
    Uittenbogaart SB, Klemt-Kropp M.
    Ned Tijdschr Geneeskd; 2011 May; 155(48):A3842. PubMed ID: 22152414
    [Abstract] [Full Text] [Related]

  • 26. Ulcerative colitis patients with an inflammatory response upon mesalazine cannot be desensitized: a randomized study.
    Buurman DJ, De Monchy JG, Schellekens RC, van der Waaij LA, Kleibeuker JH, Dijkstra G.
    Scand J Gastroenterol; 2015 Apr; 50(4):399-405. PubMed ID: 25633468
    [Abstract] [Full Text] [Related]

  • 27. Three cases of mesalazine-induced pneumonitis with eosinophilia.
    Inoue M, Horita N, Kimura N, Kojima R, Miyazawa N.
    Respir Investig; 2014 May; 52(3):209-12. PubMed ID: 24853024
    [Abstract] [Full Text] [Related]

  • 28. An unusual cause of febrile hepatitis.
    Stelzer T, Kohler S, Marques Maggio E, Heuss LT.
    BMJ Case Rep; 2015 Jun 25; 2015():. PubMed ID: 26113581
    [Abstract] [Full Text] [Related]

  • 29. MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations.
    Lichtenstein GR, Kamm MA, Sandborn WJ, Lyne A, Joseph RE.
    Aliment Pharmacol Ther; 2008 Jun 01; 27(11):1094-102. PubMed ID: 18363894
    [Abstract] [Full Text] [Related]

  • 30. [Differential diagnosis problem of pulmonary changes in ulcerative colitis].
    Djurić M, Povazan D, Secen S, Jović J.
    Vojnosanit Pregl; 2010 Jun 01; 67(6):511-4. PubMed ID: 20629432
    [Abstract] [Full Text] [Related]

  • 31. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S, Doldo P, Ranzi T, Sturniolo GC, Giglio LA, Annese V, D'Arienzo A, Gaia E, Gullini S, Riegler G, Valentini M, Massa P, Del Piano M, Rossini F, Guidetti CS, Pera A, Greinwald R, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Nov 01; 31(8):677-84. PubMed ID: 10730559
    [Abstract] [Full Text] [Related]

  • 32. Mesalazine-induced psoriasis in patients with inflammatory bowel diseases.
    Di Cesare A, Fidanza R, Riitano A, Fargnoli MC, Peris K.
    Eur J Dermatol; 2011 Nov 01; 21(5):784-5. PubMed ID: 21697068
    [No Abstract] [Full Text] [Related]

  • 33. Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.
    Miner PB, Wedel MK, Xia S, Baker BF.
    Aliment Pharmacol Ther; 2006 May 15; 23(10):1403-13. PubMed ID: 16669955
    [Abstract] [Full Text] [Related]

  • 34. Pulmonary complications in patients with inflammatory bowel disease.
    Kuzela L, Vavrecka A, Prikazska M, Drugda B, Hronec J, Senkova A, Drugdova M, Oltman M, Novotna T, Brezina M, Kratky A, Kristufek P.
    Hepatogastroenterology; 1999 May 15; 46(27):1714-9. PubMed ID: 10430329
    [Abstract] [Full Text] [Related]

  • 35. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.
    Marteau P, Probert CS, Lindgren S, Gassul M, Tan TG, Dignass A, Befrits R, Midhagen G, Rademaker J, Foldager M.
    Gut; 2005 Jul 15; 54(7):960-5. PubMed ID: 15951542
    [Abstract] [Full Text] [Related]

  • 36. [Interstitial nephritis associated with mesalazine therapy].
    Vuotila M, Ikäheimo R, Pietiläinen T.
    Duodecim; 2003 Jul 15; 119(20):1978-82. PubMed ID: 14640003
    [No Abstract] [Full Text] [Related]

  • 37. Mesalazine (5-aminosalicylic acid) micropellets show similar efficacy and tolerability to mesalazine tablets in patients with ulcerative colitis--results from a randomized-controlled trial.
    Raedler A, Behrens C, Bias P.
    Aliment Pharmacol Ther; 2004 Dec 15; 20(11-12):1353-63. PubMed ID: 15606398
    [Abstract] [Full Text] [Related]

  • 38. Mesalamine lung toxicity.
    Jain N, Petruff C, Bandyopadhyay T.
    Conn Med; 2010 May 15; 74(5):265-7. PubMed ID: 20509416
    [Abstract] [Full Text] [Related]

  • 39. [Renal involvement in patients with chronic inflammatory intestinal disease treated with mesalazine. How to prevent its nephrotoxicity?].
    Bonet J, Vaquero M, Bayés B, Romero R.
    Med Clin (Barc); 1999 Jul 10; 113(5):199. PubMed ID: 10480148
    [No Abstract] [Full Text] [Related]

  • 40. Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis.
    Fleming K, Ashcroft A, Alexakis C, Tzias D, Groves C, Poullis A.
    World J Gastroenterol; 2015 Mar 21; 21(11):3376-9. PubMed ID: 25805947
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.